Keyword Connections

cd39

Journals

2

1 advances in experimental medicine and biology

2 slas discovery : advancing life sciences r & d

Research Groups

0

No Research Group Connected

Bibliographies

36

1 Adenosine Signaling in Glioma Cells.

2 High-Throughput Screening Assays for Cancer Immunotherapy Targets: Ectonucleotidases CD39 and CD73.

3 extracellular adenosine generation in the regulation of pro-inflammatory responses and pathogen colonization

4 ectonucleoside triphosphate diphosphohydrolase-1/cd39 affects the response to adp of female rat platelets

5 P2X7 receptor activation increases caveolin-1 expression and macrophage lipid raft formation boosting CD39 activity.

6 Control of Metastases via Myeloid CD39 and NK Cell Effector Function.

7 Susceptibility of aging mice to listeriosis: Role of anti-inflammatory responses with enhanced Treg-cell expression of CD39/CD73 and Th-17 cells.

8 Circulating gluten-specific, but not CMV-specific, CD39 regulatory T cells have an oligoclonal TCR repertoire.

9 Ectonucleotidase CD39 and Checkpoint Signalling Receptor Programmed Death 1 are Highly Elevated in Intratumoral Immune Cells in Non–small-cell Lung Cancer

10 Targeting CD39 in cancer reveals an extracellular ATP-and inflammasome-driven tumor immunity

11 The Inhibition of CD39 and CD73 Cell Surface Ectonucleotidases by Small Molecular Inhibitors Enhances the Mobilization of Bone Marrow Residing Stem Cells by Decreasing the Extracellular Level of Adenosine

12 Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation

13 Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients

14 CD8+CD103+ iTregs Inhibit Chronic Graft-versus-Host Disease with Lupus Nephritis by the Increased Expression of CD39

15 Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis

16 Author Correction: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39 (Nature Neuroscience, (2019), 22, 5, (729-740), 10.1038/s41593-019-0370-y)

17 CD39 downregulation in chronic intervillositis of unknown etiology

18 CD49b, CD87, and CD95 Are Markers for Activated Cancer-Associated Fibroblasts Whereas CD39 Marks Quiescent Normal Fibroblasts in Murine Tumor Models

19 The abnormal function of CD39<sup>+</sup> regulatory T cells could be corrected by high-dose dexamethasone in patients with primary immune thrombocytopenia

20 Identification and characterization of ecto-nucleoside triphosphate diphosphohydrolase 1 (CD39)involved in regulating extracellular ATP-mediated innate immune responses in Japanese flounder (Paralichthys olivaceus)

21 Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39

22 Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease

23 CD133 <sup>+</sup> bone marrow stem cells (BMSC) control platelet activation – Role of ectoNTPDase-1 (CD39)

24 The role of NK cells and CD39 in the immunological control of tumor metastases

25 CD39 identifies a microenvironment-specific anti-inflammatory CD8 <sup>+</sup> T-cell population in atherosclerotic lesions

26 Physical fitness modulates the expression of CD39 and CD73 on CD4 <sup>+</sup> CD25 <sup>−</sup> and CD4 <sup>+</sup> CD25 <sup>+</sup> T cells following high intensity interval exercise

27 Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients

28 Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

29 Human gingival tissue-derived MSC suppress osteoclastogenesis and bone erosion via CD39-adenosine signal pathway in autoimmune arthritis

30 Targeting CD39 Toward Activated Platelets Reduces Systemic Inflammation and Improves Survival in Sepsis: A Preclinical Pilot Study

31 Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39

32 HO-1 and CD39: It Takes Two to Protect the Realm

33 Mass Cytometry Discovers Two Discrete Subsets of CD39−Treg Which Discriminate MGUS From Multiple Myeloma

34 Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients

35 rapamycin regulates itreg function through cd39 and runx1 pathways

36 elevated mir-155 expression induces immunosuppression via cd39+ regulatory t-cells in sepsis patient